Foxp3+ Treg cells can inhibit Th17- and Th- cell-mediated inflammatory responses and prevent bronchial AHR and airway inflammation both in animal models and in patients with asthma; the functions of Foxp3+ Treg cells are impaired in asthma [52]. Here, FOXP3 is linked to asthma.